Position in AVXL
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$102,013
+$18,923 QoQ
Shares Held
33,229
+42.4% QoQ
Ownership
0.036%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2024
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AVXL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Atria Investments, Inc holds $45,793,567 across 38 Biotechnology names. AVXL ranks #35 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
27,342 | $12,209,296 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
11,461 | $8,855,227 | |
| 3 | INSM |
INSMED Inc
|
21,845 | $3,572,094 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
9,874 | $3,267,010 | |
| 5 | ROIV |
Roivant Sciences Ltd.
|
64,082 | $1,775,071 | |
| 6 | ARGX |
Argenx SE
|
2,001 | $1,461,230 | |
| 7 | GMAB |
Genmab A/S
|
45,416 | $1,218,511 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
17,877 | $1,155,390 |
All Filings in AVXL
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $102,013 | 33,229 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $83,090 | 23,340 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $186,107 | 20,911 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $203,854 | 22,110 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $160,480 | 18,704 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $243,626 | 22,684 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $75,544 | 13,300 | Shares | Sole | 2024-11-01 | |
| No filing history on record for this holder in this stock. | ||||||